Russia is ready to produce a coronavirus vaccine in Algeria, Russian Ambassador to the North African country, Igor Belyaev, announced yesterday.
“Russia is ready to cooperate with Algeria to design a vaccine on the local level,” Belyaev told Sputnik, adding that he had discussed the matter with the Algerian health and pharmaceutical industry minister.
Belyaev pointed out that the Russian Direct Investment Fund (RDIF) was offering “various forms of cooperation, including direct acquisition, technology transfer, joint production and participation in the third phase of the trial.”
“These are the forms of cooperation which we offered to the Algerian side,” he added.
Russia’s so-called “Sputnik V” was registered in August as the world’s first registered vaccine against the novel coronavirus. It was developed by the Russian Gamaleya Research Institute of Epidemiology and Microbiology with support from the sovereign wealth fund. It is currently undergoing phase 3 clinical trials.
There are a total of 2,515,009 people infected with COVID-19 in Russia, 44,159 of whom have died, and 1,981,526 others have recovered, according to the US Worldometers.